share_log

T2 Biosystems | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

SEC ·  May 7, 2024 05:30

Summary by Moomoo AI

T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, has filed an amendment to its Form S-1 registration statement with the Securities and Exchange Commission (SEC) on May 6, 2024. The amendment relates to a proposed offering of up to 3,322,259 shares of common stock, along with Pre-Funded Warrants and Series B-1 and Series B-2 Common Warrants to purchase an equal number of shares. The offering is on a 'reasonable best efforts' basis, with no minimum number of securities required to be sold. The company's common stock is listed on the Nasdaq Capital Market under the symbol 'TTOO.' The offering aims to raise capital for working capital and general corporate purposes, including sales and marketing, manufacturing, and clinical development costs. The offering is expected to close on or about May 15, 2024, subject to customary closing conditions.
T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, has filed an amendment to its Form S-1 registration statement with the Securities and Exchange Commission (SEC) on May 6, 2024. The amendment relates to a proposed offering of up to 3,322,259 shares of common stock, along with Pre-Funded Warrants and Series B-1 and Series B-2 Common Warrants to purchase an equal number of shares. The offering is on a 'reasonable best efforts' basis, with no minimum number of securities required to be sold. The company's common stock is listed on the Nasdaq Capital Market under the symbol 'TTOO.' The offering aims to raise capital for working capital and general corporate purposes, including sales and marketing, manufacturing, and clinical development costs. The offering is expected to close on or about May 15, 2024, subject to customary closing conditions.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Related Stocks Related Stocks
    Symbol Mini Chart Price
    Tesla
    TSLA
    -- 358.388
    NVIDIA
    NVDA
    -- 142.640
    Alibaba
    BABA
    -- 127.390
    Baidu
    BIDU
    -- 91.775
    Intel
    INTC
    -- 24.940
    Log In for the Full List
    Reassessing Chinese Assets
    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
    Discussing
    FOMC leaves rates unchanged, how will you adjust your portfolio?
    FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
    FOMC Press Conference, January 29, 2025